ÌÇÐĹÙÍø Web Education – straight from the experts to you
ÌÇÐĹÙÍø Gut Highlights April 2026
Pancreatic fluid collections (PFCs), including walled-off necrosis (WON) and pancreatic pseudocysts (PCs), are important local complications of severe acute pancreatitis. Endoscopic ultrasound (EUS)-guided transmural drainage now sits as the preferred first-line approach for symptomatic collections, but it remains invasive and can lead to bleeding, perforation, longer admissions, and occasional mortality.
ÌÇÐĹÙÍø Gut Highlights March 2026
Studies have shown significant differences in microbiome patterns of patients with acute pancreatitis (AP). In this study, Ammer-Herrmenau et al. prospectively followed patients with AP from the Pancreatitis-Microbiome As Predictor of Severity (P-MAPS) I cohort.
ÌÇÐĹÙÍø Gut Highlights February 2026
Functional dyspepsia (FD) is a common disorder of a likely heterogeneous aetiology. Previous studies have shown two FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols), fructans and fructose, can interfere with gastric accommodation.
ÌÇÐĹÙÍø Gut Highlights January 2026
The majority of patients (52%) with pancreatic ductal adenocarcinoma (PDAC) have metastasis at diagnosis, making surgical resection unfeasible. Current imaging modalities (CT, MRI and PET-CT) have limitations in diagnosing small, inconspicuous metastasis particularly in metabolically active organs.
ÌÇÐĹÙÍø Gut Highlights December 2025
Endoscopic submucosal dissection (ESD) has increasingly been utilised for resection of superficial neoplastic colorectal lesions larger than ≥20mm in size. However, ESD requires technical expertise and comes with risks such as bleeding and perforation.
ÌÇÐĹÙÍø Gut Highlights November 2025
The role for cold-snare endomucosal resection (EMR) polypectomy in the resection of non-pedunculated colonic polyps >20 mm is uncertain. Current practice favours the use of hot EMR for these lesions. Cold EMR theoretically carries fewer risks, including lower rates of deep mural injury, bleeding, post polypectomy syndrome and perforation. This multi-centred USA and Canada-based randomised control trial (RCT) compared approaches.
ÌÇÐĹÙÍø Gut Highlights October 2025
Human albumin solution (HAS) is an essential therapy in decompensated cirrhosis. Despite the infectious risk and unacceptability in some cultures of using human products, plasma-derived human serum albumin (pHSA) remains the only source of HAS.
ÌÇÐĹÙÍø Gut Highlights September 2025
Dietary influence on the development and/or propagation of Crohn’s disease remains a key interest. Diet is a potent modulator of the gut microbiome (community of microorganisms in the gut), which in turn impacts intestinal inflammation.
.png?width=1600&height=900&ext=.png)
ÌÇÐĹÙÍø Gut Highlights August 2025
There has been an increasing appreciation for the potential importance of bile acids and their effect on inflammatory pathways both in intestinal inflammation as well as cholestatic liver disease.
ÌÇÐĹÙÍø Gut Highlights June 2025
The ATLANTIS trial (AmitripTyline at Low-dose ANd Titrated for Irritable bowel syndrome as Second-line treatment) was a randomised, double-blind, superiority trial enrolling 463 adults with IBS (irritable bowel syndrome).
Gut Highlights May 2025
The HELIOS trial was a multicentre, open-label, randomised controlled trial comparing high-definition (HD) white-light endoscopy (WLE) with segmental re-inspection (HD-WLE-SR; double-pass) to HD-DCE (dye-based chromoendoscopy) and single-pass HD-WLE in patients with colonic IBD undergoing surveillance.
ÌÇÐĹÙÍø Gut Highlights April 2025
Nucleos(t)ide analogues are standard of care for patients with chronic hepatitis B (CHB), however annually only 1-4% of patients on-treatment will achieve functional cure, defined as loss of HBsAg for ≥6 months.
.jpg)
The ÌÇÐĹÙÍø web team are looking for enthusiastic individuals to expand our current group of web article reviewers. This could be included as part of your CPD diary and could help enrich your own knowledge too. It is a rewarding process and allows us to support our members in their education. The articles are short but require professional review and constructive comments. The commitment will be sporadic but we do ask that you’re able to return the review in a timely fashion when requested. This is open to consultants, senior registrars (ST6 and above), specialist nurses or senior allied health professionals in Gastroenterology and/or Hepatology.
Get in touch